1Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...
Abstract. Macrophages are a type of immune cell that play a crucial role in the tumor microenvironment. In tumors, macrophages can be polarized towards a pro-inflammatory phenotype, referred to as M1, ...
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
Cancer Res (2023) 83 (8_Supplement): LB215.
Cellentia Inc., Foster City, CA. Search for other works by this author on: ...
Cancer Res (2023) 83 (7_Supplement): ND02.
Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
1Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Search for other works by this author on: 1Department of Clinical Pharmacology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback